Hematology

Is Tg Therapeutics A Buy?

TG Therapeutics (NASDAQ: TGTX), a clinical-stage hematology and autoimmune disease specialist, has been crushing the broader stock market this year. The biotech's shares surged higher in response to the news that the company's relapsed and...
Related topics: Nasdaq

Read More →

Gene-based Factor Viia Prevents Bleeding Episodes In Animals With Hemophilia

Hematology researchers have further refined how a treatment currently used on an urgent basis to control bleeding in hemophilia patients holds promise as a preventive treatment as well. A study in animals may set the stage for a new therapy for a...
Related topics: Genetics, Medical Research

Read More →

January 2019 Briefing - Hematology & Oncology

Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for January 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory...
Related topics: Cancer, Oncology, Medical Research, Food And Drug Administration

Read More →

Ash Develops Practice Guidelines For Venous Thromboembolism

THURSDAY, Dec. 27, 2018 -- The American Society of Hematology (ASH) has developed new guidelines for the treatment of venous thromboembolism (VTE); the clinical practice guidelines were recently published in Blood Advances. The guidelines address...

Read More →

Health Tip: Understanding Blood Clots

-- Blood clotting is the body's way of preventing excessive bleeding when a blood vessel is injured. Typically, the body will dissolve the clot after the injury has healed, the American Society of Hematology says. But occasionally, a clot forms...

Read More →

American Society Of Hematology, Dec. 1-4

The 60th American Society of Hematology Annual Meeting and Exposition The annual meeting of the American Society of Hematology was held from Dec. 1 to 4 in San Diego and attracted approximately 22,000 participants from around the world, including...

Read More →

J&j's Blood Cancer Drugs Succeed In Label Expansion Studies

Johnson & Johnson JNJ presented positive data from late-stage label expansion studies evaluating its blood cancer drugs, Imbruvica and Darzalex, in previously untreated patients at the annual meeting of the American Society of Hematology (ASH)...
Related topics: American Cancer Society, Cancer, Oncology

Read More →

Roche Announces Positive Data On Venclexta/venclyxto At Ash

Roche Holding AG RHHBY announced new data from the phase III MURANO study on Venclexta/Venclyxto (venetoclax) in patients with previously treated chronic lymphocytic leukemia (CLL) at the American Society of Hematology (ASH) 2018 Annual...
Related topics: Medical Research, Leukemia

Read More →

November 2018 Briefing - Hematology & Oncology

Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for November 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory...
Related topics: Cancer, Oncology, Medical Research, Food And Drug Administration

Read More →

What's Hot At This Year's Ash Meeting?

Big results from big trials in leukemia and lymphoma will be presented and are 'almost certainly going to be practice changing,' says American Society of Hematology (ASH) Secretary Robert Brodsky, MD. Medscape Medical News
Related topics: Leukemia, Lymphoma

Read More →

Here's Why Sangamo Therapeutics Lost 12% Today

After reporting preliminary results for its hemophilia A therapy that excited investors in August, Sangamo Therapeutics (NASDAQ: SGMO) has backed away from plans to present the data at the fast-approaching American Society of Hematology (ASH)...
Related topics: Nasdaq

Read More →

September 2018 Briefing - Hematology & Oncology

Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for September 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and...
Related topics: Cancer, Oncology, Medical Research, Food And Drug Administration

Read More →

Fostamatinib Seems Effective For Immune Thrombocytopenia

WEDNESDAY, Sept. 5, 2018 -- Fostamatinib produces clinically meaningful responses in adults with immune thrombocytopenia (ITP), according a study published in the July issue of the American Journal of Hematology. James Bussel, M.D., from Weill...
Related topics: Medical Research

Read More →

Mount Sinai Receives $4 Million Grant To Study Use Of Inhaled Corticosteroids For Sickle Cell...

The Departments of Emergency Medicine and Hematology at the Icahn School of Medicine at Mount Sinai have been awarded a $4 million grant from the National Institutes of Health toward further study of inhaled corticosteroids to treat sickle cell...
Related topics: Medical Research

Read More →

Pixcell Medical Presents The Hemoscreen: Blood Testing At The Point Of Care

PixCell is a cell based diagnostics company that has developed the HemoScreen: the first true Point of Care (POC) Hematology analyzer that uses a self-contained disposable cartridge, preventing the need for any maintenance or calibrations. The...

Read More →

Pixcell Medical Presents The Hemoscreen: Blood Testing At The Point Of Care

PixCell is an ISO 13485 certified cell diagnosis company that has developed the HemoScreen: the first true Point of Care (POC) Hematology analyzer that uses a self-contained disposable cartridge, preventing the need for any maintenance or...

Read More →

June 2018 Briefing - Hematology & Oncology

Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for June 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory...
Related topics: Cancer, Oncology, Medical Research, Food And Drug Administration

Read More →

National Comprehensive Cancer Network Begins Work On Guidelines To Improve Cancer Care In The...

National Comprehensive Cancer Network collaborates with the Caribbean Association for Oncology & Hematology to create NCCN Harmonized Guidelines for the Caribbean
Related topics: Cancer, Oncology

Read More →

Cedars-sinai Investigator Awarded Grant To Study Esophageal Cancer

Dechen Lin, PhD, a research scientist in the Division of Hematology and Oncology in the Cedars-Sinai Department of Medicine, has been awarded $175,000 from the Price Family Foundation and the DeGregorio Family Foundation for Gastric and Esophageal...
Related topics: Medical Research, Esophageal Cancer, Cancer, Oncology

Read More →

A Physician Sees End-of-life Care Through A Religious Lens

In my second year of residency, I was on the hematology/oncology service where we were taking care of a pleasant lady in her 80s who was admitted with pancreatic cancer. It was apparent that the disease had spread rapidly, and when we discussed her...
Related topics: Religion, Cancer, Oncology, Pancreatic Cancer

Read More →
What is noozilla?
Noozilla is an independent news aggregation service with a categorization engine that categorizes millions of news stories by subject.